1[1]Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dessection for gastric cancer. Dutch Cancer Group. N Engl J Med1999;340:908-914.
2[2]Yoo CH, Noh SH, Shin DW, et al. Rrcurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242.
3[3]Castells A, Rstgi AK. Tumor growth, invasion and metastasis. In Gastrointestinal Cancer, Rustgi AK, Crawford JM (eds) pp 69-80.Philadelphia: Saunders
4[4]Sauter ER, Nesbit M. Vascular endothelial growth factor is a market of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999;5:775-782.
5[5]Yamamoto Y, Toi M, Kondo S, et al. Concentration of vascular endothelial growth factor in sera of normal controls and cancer patients. Clin Cancer Res 1996;2:821-826.
6[6]Salven P, Rotsalainen T, Mattson K, et al. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 1998;79:144-146.
7[7]Chin KF, Greenman J, Gardiner E, et al. Pre-operative serum vascular endothelial growth factor can select patients or adjuvant treatment after curative resection in colorectal cancer. Br J Cancer2000;83:1425-1431.
8[8]Feldman AL, Tamarkin L, Paciotti GF, et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage Ⅳ clear cell renal cancer. Clin Cancer Res 2000;6:4628-4634.
9[9]Tempfer C, Obermair A, Hefler L, et al. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obster Gynecol1998;92:360-363.
10[10]Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 2001;233:227-235.
